K. Debrah et al., EFFECT OF CAFFEINE ON RECOGNITION OF AND PHYSIOLOGICAL-RESPONSES TO HYPOGLYCEMIA IN INSULIN-DEPENDENT DIABETES, Lancet, 347(8993), 1996, pp. 19-24
Background For the patient with diabetes, hypoglycaemia unawareness-ie
, the warning signs of falling blood glucose are missing-is potentiall
y dangerous. One study has suggested that, in healthy volunteers, caff
eine might be a helpful treatment. Our study looked at two effects of
caffeine ingestion (250 mg) on the brain-namely, a decrease in cerebra
l blood flow and an increase in brain glucose use-to see if the recogn
ition of and physiological responses to hypoglycaemia were altered in
patients with insulin-dependent diabetes mellitus (IDDM). Methods 12 p
atients were studied twice. A hyperinsulinaemic glucose clamp was used
to maintain plasma glucose at 5 mmol/L for 90 min, followed by 60 min
at 3.8 mmol/L, and then 2.8 mmol/L for a further hour. After 30 min a
t 5 mmol/L, patients consumed, in a double-blind, crossover design, 25
0 mg caffeine or matched placebo. We recorded middle cerebral artery v
elocity (V-MCA), counterregulatory hormone levels, and cognitive funct
ion, and patients recorded hypoglycaemia symptoms on a visual analogue
scale. Results Caffeine caused an immediate and sustained fall in V-M
CA of 10 cm/s, from 60 to 50 cm/s (95% Cl -5 to -15 cm/s; p<0.001). At
a blood glucose of 3.8 mmol/L, plasma adrenaline levels were twice as
high after caffeine than after placebo (difference 524 pmol/L). When
glucose was lowered to 2.8 mmol/L, caffeine ingestion was associated w
ith: greater awareness of hypoglycaemia in 9 patients, significantly m
ore intense autonomic and neuroglycopenic symptoms, and higher levels
of adrenaline, cortisol, and growth hormone. Cognitive function (laten
cy of P-300 evoked potentials) deteriorated to the same extent in both
studies at this glucose level. Interpretation The sustained fall in V
-MCA and augmented sympathoadrenal and symptomatic responses during mo
derate hypoglycaemia suggest caffeine as a potentially useful treatmen
t for diabetic patients who have difficulty recognising the onset of h
ypoglycaemia.